Baseline mean compliance rates and mean changes in compliance rates across practices by trial group
| No of practices | No of decisions | Compliance rate (%) | ||||
|---|---|---|---|---|---|---|
| Medical condition; indicator (number of key recommendations included in the indicator) | Baseline | Post-intervention | Baseline | Post-intervention | Baseline mean (95% CI) | Mean change (95% CI) |
| *Increasing the dosage or starting a drug from a different class in case of a diastolic blood pressure above 90 mm Hg. | ||||||
| Newly diagnosed hypertension; assessment of risk factors (9) | ||||||
| Intervention | 46 | 40 | 1098 | 837 | 79 (75 to 83) | –2 (–9 to 5) |
| Control | 48 | 44 | 1377 | 963 | 75 (71 to 79) | 0 (–6 to 6) |
| Newly diagnosed hypertension; provision of information and advice (10) | ||||||
| Intervention | 46 | 40 | 860 | 688 | 57 (50 to 65) | 5 (–6 to 16) |
| Control | 48 | 44 | 1102 | 742 | 54 (48 to 60) | –1 (–10 to 8) |
| Treated hypertension; provision of information and advice (5) | ||||||
| Intervention | 62 | 61 | 4822 | 3585 | 64 (59 to 70) | 5 (–1 to 10) |
| Control | 62 | 60 | 4567 | 3991 | 57 (52 to 63) | –3 (–8 to 2) |
| Treated hypertension; increasing the antihypertensive medication* (1) | ||||||
| Intervention | 62 | 57 | 700 | 446 | 31 (26 to 37) | 8 (–1 to 16) |
| Control | 61 | 60 | 681 | 567 | 32 (28 to 37) | 4 (–3 to 11) |
| Treated hypertension; scheduling a follow up appointment (3) | ||||||
| Intervention | 62 | 61 | 1756 | 1382 | 76 (72 to 80) | 1 (–4 to 6) |
| Control | 62 | 60 | 1615 | 1551 | 72 (66 to 77) | 0 (–5 to 5) |
| Hypercholesterolaemia; assessment of risk factors (9) | ||||||
| Intervention | 53 | 51 | 2223 | 1566 | 90 (87 to 93) | 5 (2 to 8) |
| Control | 57 | 53 | 2592 | 1548 | 89 (86 to 92) | 2 (–2 to 5) |
| Hypercholesterolaemia; provision of information and advice (7) | ||||||
| Intervention | 53 | 51 | 1449 | 1036 | 77 (72 to 82) | 7 (1 to 13) |
| Control | 57 | 53 | 1699 | 1019 | 77 (73 to 80) | 0 (–6 to 6) |
| Angina pectoris; assessment of risk factors (2) | ||||||
| Intervention | 48 | 39 | 292 | 246 | 89 (85 to 93) | 8 (2 to 15) |
| Control | 46 | 24 | 280 | 170 | 92 (89 to 96) | 0 (–7 to 6) |
| Angina pectoris; provision of information and advice (4) | ||||||
| Intervention | 48 | 39 | 341 | 348 | 69 (63 to 76) | –7 (–18 to 4) |
| Control | 46 | 24 | 325 | 222 | 67 (60 to 75) | –9 (–23 to 4) |
| Angina pectoris; prescribing aspirin and sublingual nitrate (2) | ||||||
| Intervention | 49 | 41 | 338 | 296 | 55 (48 to 62) | 10 (–1 to 21) |
| Control | 49 | 26 | 332 | 194 | 54 (48 to 60) | 1 (–14 to 17) |
| Heart failure; checking for clinical signs of deterioration (4) | ||||||
| Intervention | 41 | 25 | 460 | 300 | 78 (71 to 85) | 12 (0 to 25) |
| Control | 36 | 22 | 484 | 304 | 83 (77 to 89) | –7 (–17 to 2) |
| Heart failure; provision of information and advice (3) | ||||||
| Intervention | 41 | 25 | 345 | 225 | 80 (73 to 86) | 0 (–8 to 8) |
| Control | 36 | 22 | 363 | 228 | 79 (73 to 85) | 6 (–2 to 15) |